| CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles D Beier, P Hau, M Proescholdt, A Lohmeier, J Wischhusen, PJ Oefner, ... Cancer research 67 (9), 4010-4015, 2007 | 1475 | 2007 |
| Temozolomide preferentially depletes cancer stem cells in glioblastoma D Beier, S Röhrl, DR Pillai, S Schwarz, LA Kunz-Schughart, P Leukel, ... Cancer research 68 (14), 5706-5715, 2008 | 396 | 2008 |
| Chemoresistance of glioblastoma cancer stem cells-much more complex than expected D Beier, JB Schulz, CP Beier Molecular cancer 10, 1-11, 2011 | 375 | 2011 |
| Transcriptional Profiles of CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin C Lottaz, D Beier, K Meyer, P Kumar, A Hermann, J Schwarz, M Junker, ... Cancer research 70 (5), 2030-2040, 2010 | 305 | 2010 |
| Lactate promotes glioma migration by TGF-β2–dependent regulation of matrix metalloproteinase-2 F Baumann, P Leukel, A Doerfelt, CP Beier, K Dettmer, PJ Oefner, ... Neuro-oncology 11 (4), 368-380, 2009 | 286 | 2009 |
| In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study K Knudsen, TD Fedorova, AK Hansen, M Sommerauer, M Otto, ... The Lancet Neurology 17 (7), 618-628, 2018 | 265 | 2018 |
| Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma J Wischhusen, G Jung, I Radovanovic, C Beier, JP Steinbach, A Rimner, ... Cancer research 62 (9), 2592, 2002 | 256 | 2002 |
| CAMTA1 is a novel tumour suppressor regulated by miR‐9/9* in glioblastoma stem cells D Schraivogel, L Weinmann, D Beier, G Tabatabai, A Eichner, JY Zhu, ... The EMBO journal 30 (20), 4309-4322, 2011 | 200 | 2011 |
| CD133 expression and cancer stem cells predict prognosis in high‐grade oligodendroglial tumors D Beier, J Wischhusen, W Dietmaier, P Hau, M Proescholdt, A Brawanski, ... Brain pathology 18 (3), 370-377, 2008 | 187 | 2008 |
| Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells F Reim, Y Dombrowski, C Ritter, M Buttmann, S Häusler, M Ossadnik, ... Cancer research 69 (20), 8058-8066, 2009 | 165 | 2009 |
| Cascade of caspase activation in potassium-deprived cerebellar granule neurons: targets for treatment with peptide and protein inhibitors of apoptosis E Gerhardt, S Kügler, M Leist, C Beier, L Berliocchi, C Volbracht, M Weller, ... Molecular and Cellular Neuroscience 17 (4), 717-731, 2001 | 112 | 2001 |
| RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma-a phase II study CP Beier, C Schmid, T Gorlia, C Kleinletzenberger, D Beier, O Grauer, ... BMC cancer 9, 1-10, 2009 | 109 | 2009 |
| Glioblastoma cancer stem cells–from concept to clinical application BE Stopschinski, CP Beier, D Beier Cancer letters 338 (1), 32-40, 2013 | 104 | 2013 |
| Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma A Schäfer, J Teufel, F Ringel, M Bettstetter, I Hoepner, M Rasper, J Gempt, ... Neuro-oncology 14 (12), 1452-1464, 2012 | 101 | 2012 |
| The cancer stem cell subtype determines immune infiltration of glioblastoma CP Beier, P Kumar, K Meyer, P Leukel, V Bruttel, I Aschenbrenner, ... Stem cells and development 21 (15), 2753-2761, 2012 | 91 | 2012 |
| FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidylinositol 3-kinase-Akt/protein kinase B-dependent expression of lifeguard/neuronal membrane protein 35 CP Beier, J Wischhusen, M Gleichmann, E Gerhardt, A Pekanovic, ... Journal of Neuroscience 25 (29), 6765-6774, 2005 | 80 | 2005 |
| Chemotherapy increases long-term survival in patients with adult medulloblastoma—a literature-based meta-analysis S Kocakaya, CP Beier, D Beier Neuro-oncology 18 (3), 408-416, 2015 | 70 | 2015 |
| High levels of c-Met is associated with poor prognosis in glioblastoma SA Petterson, RH Dahlrot, SK Hermansen, S KA Munthe, MT Gundesen, ... Journal of neuro-oncology 122, 517-527, 2015 | 70 | 2015 |
| Fas/CD95 regulatory protein Faim2 is neuroprotective after transient brain ischemia A Reich, C Spering, K Gertz, C Harms, E Gerhardt, G Kronenberg, ... Journal of Neuroscience 31 (1), 225-233, 2011 | 70 | 2011 |
| Epidemiology and outcome of idiopathic generalized epilepsy in adults J Gesche, J Christensen, H Hjalgrim, G Rubboli, CP Beier European Journal of Neurology 27 (4), 676-684, 2020 | 63 | 2020 |
